On this episode of Growth Stories, we take a look at the escalating rivalry between Novo Nordisk and Eli Lilly and how the Danish drugmaker lost its grip on the weight-loss drug market.  Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of Growth Stories, we talk to Nano Nuclear Energy CEO James Walker to learn about the company's quest to bring portable nuclear power to market. Learn more about your ad choices. Visit megaphone.fm/adchoices

Wall Street's most exclusive club consists of companies with market caps over a trillion dollars. And Netflix wants to add its name to that list. On this episode of Growth Stories, we take a look at the company's bold growth goals and explore whether the streaming titan is poised for a blockbuster performance or disappointing fizzle. Learn more about your ad choices. Visit megaphone.fm/adchoices

A new trade agreement with China is catapulting a group of organic heavy metals into the spotlight. On this episode of Growth Stories, we delve into the world of rare earths and explore how recent trade talks have brought this often-overlooked market into global focus. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of Growth Stories, we take a look at the groundbreaking tests that could revolutionize cancer detection and what investors need to know about this evolving market. Learn more about your ad choices. Visit megaphone.fm/adchoices

The AI revolution is rewriting the rules of cybersecurity and the financial stakes are massive. But this isn't just about market growth; it's a high-stakes arms race. As cybersecurity giants like Palo Alto Networks deploy AI defenses, cybercriminals are equally quick to weaponize advanced technology for increasingly sophisticated attacks. Wendi Whitmore, chief security intelligence officer at Palo Alto Networks, discusses cybersecurity themes for 2025 and what investors need to know. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of Growth Stories, we're joined by Nvidia's vice president of omniverse and simulation technology Rev Lebaredian, to hear how the AI titan plans to ignite a new growth chapter by bringing AI into the physical world. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of Growth Stories, we take a look at Palantir CEO Alex Karp's plans to redefine the military industrial complex and how defense companies are maneuvering to stay competitive in the age of artificial intelligence. Learn more about your ad choices. Visit megaphone.fm/adchoices

While demand for AI chips has driven Nvidia stock's astronomical climb over the last few years, earnings growth has been decelerating and more rivals are looking to gain market share by producing their own high-powered chips. That has left investors to wonder if Nvidia can keep the party going as the competition heats up. On this episode of Growth Stories, we dive into Nvidia's 2025 outlook and how CEO Jensen Huang plans to keep the chipmaker front and center of the AI revolution. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this Growth Stories Spotlight, we talk to Sam Rubin, VP & global head operations of Unit 42 at Palo Alto Networks, to discuss AI's role in cybersecurity and key themes for the industry in the year ahead. Learn more about your ad choices. Visit megaphone.fm/adchoices

America has led the world in designing and building the most advanced chips in the market. But that position is being challenged as big manufacturing hubs like Taiwan and Korea rise in prominence. And massive government spending efforts in China to bolster its chip industry also threaten to upend the U.S.’s competitive advantage in the sector. Policymakers have responded with subsidies to boost domestic chipmakers and bring some components of production back to U.S. soil. But industry leaders say it will be a long road. On this Growth Stories Spotlight, we speak to Chris Miller, economic historian and author of the book “Chip War: The Fight for the World’s Most Critical Technology,” to get his thoughts on the state of the industry and the race to reassert America’s dominance over the global semiconductor sector. Learn more about your ad choices. Visit megaphone.fm/adchoices

Over the last decade, cell therapies have attracted a lot of investor attention to biotechs. These groundbreaking treatments use a patient's own cells to create personalized medicine that not only improves wellness outcomes for people, but it has the ability to transform the health care and pharmaceutical industries. On this Growth Stories Spotlight, we talk to Vericel CEO Nick Colangelo to get his insights on the cell therapy market, his plans to expand MACI and burn care treatments and why he thinks Vericel has a unique position in the competitive landscape. Learn more about your ad choices. Visit megaphone.fm/adchoices

Tesla is looking for its next big win. And the company is focusing on self-driving cars as a key part of its long-term strategy. On this Growth Stories Spotlight, we take a look at Tesla's upcoming robotaxi event and why the company is centering its future around a technology it's had trouble executing — and how the investing community might react. Learn more about your ad choices. Visit megaphone.fm/adchoices

What market saw record sales growth last year and is considered a disappointment? That would be electric vehicles. Back in 2021, automakers went all in on battery-powered cars, committing billions of dollars to EV production. But just a few years later, that future is looking a bit hazy as a host of factors have seemingly put the brakes on the EV transition. And consumers who aren't ready to go all in on battery power are turning more and more to hybrid models. On this episode of Growth Stories, we take a look at the evolving electric vehicle market and what those changes signify for automakers—and investors—as they navigate the EV transition. Learn more about your ad choices. Visit megaphone.fm/adchoices

Since its market debut in 2017, Celsius has been 'bubbling' up explosive growth for investors. But the company's turbocharged performance has set a high bar — leaving investors and Wall Street to wonder if Celsius' fast pace of growth is sustainable. On this Growth Stories Spotlight, Celsius CEO John Fieldly talks about the energy drink market and the growth drivers pushing Celsius forward in the year ahead. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this Growth Stories Spotlight, Informatica CEO Amit Walia gives us details on how the AI megatrend is boosting cloud computing growth and why being the Switzerland of data is helping the company stand out in the competitive data management landscape. Learn more about your ad choices. Visit megaphone.fm/adchoices

Since its blockbuster return to the public market in September 2023, chip designer Arm has dazzled investors with its strong price history. And while the company is known for its mobile phone technology, CEO Rene Haas has signaled that Arm’s automotive segment is a key area of focus as the era of smart cars has upped the demand — and price — for the high-performing chips powering our vehicles.  On this Growth Stories Spotlight, Arm’s head of automotive Dipti Vachani takes us on a deep dive into the chip designer’s strategy and why the company is focused on the auto segment as a pillar of future success. Learn more about your ad choices. Visit megaphone.fm/adchoices

It's been a bumpy ride for Tesla stock over the last year as the EV automaker deals with increased competition and softening demand. As Elon Musk tries to navigate the company through choppy growth waves, will investors' patience with Tesla chart the same course? IBD news editor Ed Carson breaks down the bull and bear cases for Tesla stock. Learn more about your ad choices. Visit megaphone.fm/adchoices

Adobe was one of the hottest stocks in 2023 thanks to the artificial intelligence tidal wave. But that growth has slowed as the AI feeding frenzy begins to settle. Adobe saw a similar pullback last year before the introduction of Firefly propelled shares higher. And with new AI powered-tools taking center stage at this year’s Adobe Summit, investors will find out if Adobe stock will sing a similar tune — or fall out of rhythm with the market. On this Growth Stories Spotlight, we speak to Anil Chakravarthy, who heads the digital experience business at Adobe, to get an inside look at the company’s AI strategy and the road ahead. Learn more about your ad choices. Visit megaphone.fm/adchoices

Biotech stocks could be at a major turning point after FDA approval of the first gene editing drug using CRISPR technology to treat sickle cell disease. Government approval of these groundbreaking treatments could generate an unprecedented wave of medical innovation. But gene editing therapies aren't without risk, and questions remain about the safety and cost effectiveness of these experimental treatments. On this episode of Growth Stories, we dive into the science of gene editing treatments and how the boom in gene therapy drug approvals could transform the healthcare industry. Learn more about your ad choices. Visit megaphone.fm/adchoices